Carcinoma of the penis overview: Difference between revisions

Jump to navigation Jump to search
Line 25: Line 25:


==Differential Diagnosis==
==Differential Diagnosis==
Penile cancer must be differentiated from [[condyloma acuminata]], penile intraepithelial [[neoplasia]] (PeIN), [[balanitis xerotica obliterans]], buschke-Lowenstein [[tumour]], [[bowenoid papulosis]], and [[leukoplakia]].
Carcinoma of the penis must be differentiated from [[condyloma acuminata]], penile intraepithelial [[neoplasia]] (PeIN), [[balanitis xerotica obliterans]], buschke-Lowenstein [[tumour]], [[bowenoid papulosis]], and [[leukoplakia]].


==Prognosis==
==Prognosis==

Revision as of 12:59, 8 October 2015

Carcinoma of the penis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoma of the Penis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoma of the penis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoma of the penis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoma of the penis overview

CDC on Carcinoma of the penis overview

Carcinoma of the penis overview in the news

Blogs on Carcinoma of the penis overview

Directions to Hospitals Treating Carcinoma of the penis

Risk calculators and risk factors for Carcinoma of the penis overview

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine

Overview

Penile cancer is a malignant growth found on the skin or in the tissues of the penis. Carcinoma of the penis may be classified according to cell types into several subtypes: squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, and sarcoma. The incidence of carcinoma of the penis is approximately 1 per 100,000 men in the United States. On gross pathology, scaly patches or nodules, erythematous, and ulceration are characteristic findings of carcinoma of the penis. Common risk factors in the development of penile cancer are human papillomavirus, phimosis, poor genital hygiene, not being circumcised, weakened immune system, smoking, and treatment for psoriasis. And it is caused by an infection with human papillomavirus. The most common symptoms of penile cencer include non-healing lesion, change in the colour of the penis, redness or irritation of the penis, lump or thickening of the skin on the penis, phimosis, foul-smelling discharge or bleeding from the penis or from underneath the foreskin, itching or burning under the foreskin, swelling of the penis, lump in the groin, and dysuria. Biopsy is helpful in the diagnosis of penile cancer. The predominant therapy for penile cancer is surgical resection. Adjunctive chemotherapy, radiation therapy, and biological therapy may be required. Prognosis is generally good, and the 5-year survival rate of patients with penile cancer is approximately 67%.

Classification

Carcinoma of the penis may be classified according to cell types into several subtypes: squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, and sarcoma.

Pathophysiology

On gross pathology, scaly patches or nodules, erythematous, and ulceration are characteristic findings of carcinoma of the penis. On microscopic histopathological analysis, keratinization and intercellular bridges are characteristic findings of carcinoma of the penis.

Epidemiology and Demographics

The incidence of carcinoma of the penis is approximately 1 per 100,000 men in the United States.

Risk Factors

Common risk factors in the development of penile cancer are human papillomavirus, phimosis, poor genital hygiene, not being circumcised, weakened immune system, smoking, and treatment for psoriasis.

Screening

There is insufficient evidence to recommend routine screening for penile cancer.

Causes

Carcinoma of the penis is caused by an infection with human papillomavirus.

Differential Diagnosis

Carcinoma of the penis must be differentiated from condyloma acuminata, penile intraepithelial neoplasia (PeIN), balanitis xerotica obliterans, buschke-Lowenstein tumour, bowenoid papulosis, and leukoplakia.

Prognosis

Prognosis is generally good, and the 5-year survival rate of patients with penile cancer is approximately 67%. The prognosis varies with the stage of tumor; Stages 0–II have the most favorable prognosis.

Staging

Penile cancer may be classified into several subtypes based on TNM system and UICC staging system.

History and Symptoms

The most common symptoms of penile cencer include non-healing lesion, change in the colour of the penis, redness or irritation of the penis, lump or thickening of the skin on the penis, phimosis, foul-smelling discharge or bleeding from the penis or from underneath the foreskin, itching or burning under the foreskin, swelling of the penis, lump in the groin, and dysuria.

Physical Examination

Common physical examination findings of penile cancer include weight loss, pallor, inguinal lymphadenopathy, non-healing ulcer on the penis, mass on the penis, phimosis, skin induration on the penis, change in the colour of the penis, erythema of the penis, foul-smelling discharge or bleeding from the penis or from underneath the foreskin, and swelling of the penis.

Laboratory Tests

Some patients with penile cancer may have elevated concentration of serum calcium, which is usually suggestive of bone metastases.

X Ray

There are no x-ray findings associated with penile cancer. X-ray may be performed to detect metastases of penile cancer to lungs and bones.

CT

CT scan may be performed to detect metastases of penile cancer to surrounding lymph nodes, liver, lungs and other organs.

MRI

MRI may be helpful in the diagnosis of the extent of the penile cancer. MRI may be performed to detect metastases of penile cancer to brain, spinal cord, and nearby organs and tissues.

Ultrasound

Ultrasound may be helpful in the diagnosis of the extent of the penile cancer.

Other Imaging Findings

There are no other imaging findings associated with penile cancer.

Other Diagnostic Studies

There are no other diagnostic study findings associated with penile cancer.

Biopsy

Biopsy is helpful in the diagnosis of penile cancer.

Medical Therapy

The predominant therapy for penile cancer is surgical resection. Adjunctive chemotherapy, radiation therapy, and biological therapy may be required.

Surgery

Surgery is the mainstay of treatment for penile cancer.

Primary Prevention

Effective measures for the primary prevention of penile cancer include circumcision, good personal hygiene, and safer sexual practices. Gardasil vaccine is recommended for men to prevent HPV infection.

Secondary Prevention

There are no secondary preventive measures available for penile cancer.

References


Template:WikiDoc Sources